Illumina

Field Bioinformatics Support Scientist

Brazil

Auto‑apply with AI Apply

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Genomics, Life SciencesIndustries

Requirements

Candidates should possess a Bachelor’s degree in bioinformatics, molecular biology, genetics, or a related field, and ideally hold a Master’s or PhD degree with at least one year of relevant experience. Strong expertise in bioinformatics, data science, and systems integration is preferred, along with English fluency.

Responsibilities

The Field Bioinformatics Support Scientist will provide technical direction and support to Illumina’s Next generation Sequencing customers on Illumina Software & Analysis Products, troubleshooting bioinformatics questions via phone and email. They will also collaborate within a support team to find optimal solutions, assist customers with sequencing experiment design and interpretation, log customer issues, and meet with customers to understand their bioinformatics needs and propose solutions. Furthermore, the role involves traveling up to 70% to meet with field teams in Latin America and the USA, and collaborating with colleagues across various departments to identify new opportunities for customer assistance.

Skills

Bioinformatics

Genomics

Data Analysis

Illumina Software

Troubleshooting

Communication

Interpersonal Skills

Problem-Solving

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

Key Metrics

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free